文献速递系统性红斑狼疮

利用药房补药数据改善系统性红斑狼疮患者用药依从性的试点干预

Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-11-11

该试点干预利用药房补药数据监测系统性红斑狼疮(SLE)患者的不依从,并在门诊就诊时由医生引导讨论SLE用药。干预实施12周后,医生对可行性、可接受性和适宜性评分均较高,药物持有率(MPR)≥80%的患者比例从干预前48%升至干预后58%(P=0.03)。

要点

  • 利用药房补药数据监测不依从并在门诊讨论用药的干预具有可行性、可接受性和适宜性。
  • 干预后MPR≥80%的患者比例从48%升至58%(P=0.03),差异有统计学意义。
  • 医生对可行性、可接受性和适宜性评分分别为4.7/5、4.4/5和4.6/5。

核心结论

  • 该干预显示出可行性、可接受性和适宜性,并使依从性获得统计学显著改善。
  • 未来工作需要优化干预、在对照环境中评估其效力,并在其他门诊环境中调整使用。

研究设计与样本

  • 试点干预研究,利用药房补药数据监测不依从并在门诊就诊时由医生引导讨论SLE用药。
  • 干预通过常规门诊就诊在12周内实施,对象为服用SLE特异性药物的SLE患者。
  • 6名风湿科医生参与,130例患者纳入分析(中位年龄43岁,95%为女性,59%为种族和族裔少数群体)。

主要发现

  • 干预实施在89%的门诊记录中有文档记录。
  • 医生调查显示可行性评分4.7/5、可接受性评分4.4/5、适宜性评分4.6/5。
  • 患者调查中最常见的反应是感到坚定(32%)、被赋能(32%)和自豪(19%)。
  • MPR≥80%的患者比例从干预就诊前48%升至干预就诊后58%(P=0.03)。

关键数值与推荐

  • MPR≥80%的患者比例:干预前48% vs 干预后58%(P=0.03)。
  • 医生评分:可行性4.7/5、可接受性4.4/5、适宜性4.6/5。
  • 干预实施文档记录率89%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite high rates of medication nonadherence among patients with systemic lupus erythematosus (SLE), effective interventions to improve adherence in SLE are limited. We aimed to assess the feasibility of a pilot intervention and explore its effect on adherence. METHODS: The intervention used pharmacy refill data to monitor nonadherence and prompt discussions surrounding SLE medications during clinic encounters. Over 12 weeks, the intervention was delivered through routine clinic visits by providers to patients with SLE who take SLE-specific medications. We measured acceptability, appropriateness, and feasibility using provider surveys. We also measured acceptability by patient surveys and feasibility by medical record documentation. We explored change in adherence by comparing percent of patients with medication possession ratio (MPR) ≥80% 3 months before and after the intervention visit using the McNemar's test. RESULTS: Six rheumatologists participated; 130 patients were included in the analysis (median age 43, 95% female, and 59% racial and ethnic minorities). Implementation of the intervention was documented in 89% of clinic notes. Provider surveys showed high scores for feasibility (4.7/5), acceptability (4.4/5), and appropriateness (4.6/5). Among patient surveys, the most common reactions to the intervention visit were feeling determined (32%), empowered (32%), and proud (19%). Proportion of patients with MPR ≥80% increased from 48% to 58% (P = 0.03) after the intervention visit. CONCLUSION: Our intervention showed feasibility, acceptability, and appropriateness and led to a statistically significant improvement in adherence. Future work should refine the intervention, assess its efficacy in a controlled setting, and adapt its use among other clinic settings.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Sun K, Eudy AM, Rogers JL, et al. Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data. Arthritis Care Res (Hoboken). 2022. PMID: 34739191. doi:10.1002/acr.24806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。